Trials / Completed
CompletedNCT05365061
Periosteal Electrical Dry Needling for Knee Osteoarthritis
Periosteal Electrical Dry Needling With no Maintenance Treatments vs. Maintenance Treatments Every Other Month vs. Maintenance Treatments Once Per Month for Knee Osteoarthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 586 (actual)
- Sponsor
- Alabama Physical Therapy & Acupuncture · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to treat patients with knee osteoarthritis (OA) with periosteal electric dry needling (PEDN). It is also to determine the optimal "maintenance" regiment (i.e. maintenance treatments, one maintenance treatment every other month, or one maintenance treatment per month) required to maintain improvements in pain and function following PEDN. Physical therapists commonly use PEDN to treat knee OA, and previous studies suggest that this treatment is useful for reducing pain and improving function in patients with osteoarthritis. However, an appropriate maintenance treatment strategy to maintain these outcomes is presently unknown.
Detailed description
Patients with knee osteoarthritis will be randomized to receive periosteal electrical dry needling 1-2 treatments per week for 6 weeks (up to 10 sessions total) followed by either: 1. no maintenance treatments, 2. one maintenance treatment every other month or 3. one maintenance treatment per month.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | periosteal electrical dry needling with no maintenance treatments | periosteal electrical dry needling |
| OTHER | periosteal electrical dry needling with maintenance treatments every other month | periosteal electrical dry needling with maintenance treatments every other month |
| OTHER | periosteal electrical dry needling with monthly maintenance treatments | periosteal electrical dry needling with monthly maintenance treatments |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2024-05-01
- Completion
- 2024-05-01
- First posted
- 2022-05-09
- Last updated
- 2024-06-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05365061. Inclusion in this directory is not an endorsement.